Icu Medical Inc (ICUI) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Icu Medical’s revenue went from $379M in fiscal 2016 to $2.2B in fiscal 2025, growth of about 21.8% a year.
Net income in fiscal 2025 was $732000, a net margin of 0.0%; the best year in this period was 2021 with $103M.
Over the twelve months to September 30, 2026, revenue was $2.2B and net income $60M.
Free cash flow was $92M in fiscal 2025 and positive in 9 of the 10 years shown.
The diluted share count rose 44% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.2B | $2.4B | $2.3B | $2.3B | $1.3B | $1.3B | $1.3B | $1.4B | $1.3B | $379M |
| Gross profit | $879M | $822M | $825M | $740M | $698M | $491M | $461M | $472M | $570M | $426M | $201M |
| Operating income | $111M | $43M | $43M | $23M | -$43M | $123M | $98M | $107M | $30M | -$13M | $83M |
| Net income | $60M | $732000 | -$118M | -$30M | -$74M | $103M | $87M | $101M | $29M | $69M | $63M |
| EPS (diluted) | $2.40 | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 |
| R&D | $87M | $87M | $89M | $85M | $93M | $47M | $43M | $49M | $53M | $51M | $13M |
| Revenue growth | — | −6.3% | +5.4% | −0.9% | +73.2% | +3.6% | +0.4% | −9.6% | +8.3% | +240.7% | +11.0% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $279M | $180M | $204M | $166M | -$62M | $268M | $223M | $102M | $160M | $154M | $90M |
| Capital spending | -$71M | -$88M | -$79M | -$84M | -$90M | -$69M | -$92M | -$97M | -$93M | -$74M | -$23M |
| Free cash flow | $209M | $92M | $125M | $82M | -$152M | $199M | $131M | $5M | $67M | $80M | $67M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $9M | $12M | $9M | $11M | $8M | $13M | $19M | $6M | $4M | $17M |
| Stock-based pay | $52M | $56M | $47M | $41M | $36M | $27M | $24M | $22M | $24M | $19M | $15M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $308M | $309M | $255M | $213M | $567M | $411M | $269M | $345M | $290M | $445M |
| Debt | — | $1.3B | $1.6B | $1.7B | $1.7B | $43M | $50M | $111M | $75M | $75M | — |
| Equity | — | $2.1B | $2.0B | $2.1B | $2.1B | $1.6B | $1.5B | $1.4B | $1.3B | $1.2B | $660M |
| Total assets | — | $4.1B | $4.2B | $4.4B | $4.5B | $1.9B | $1.8B | $1.7B | $1.6B | $1.5B | $705M |
| Shares (diluted) | 25M | 25M | 24M | 24M | 24M | 22M | 22M | 22M | 22M | 21M | 17M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 40.3% | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% |
| Operating margin | 5.1% | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 2.1% | -1.0% | 21.9% |
| Net margin | 2.8% | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% |
| FCF margin | 9.6% | 4.1% | 5.2% | 3.6% | -6.7% | 15.1% | 10.3% | 0.4% | 4.8% | 6.2% | 17.5% |
| ROIC | — | 1.0% | 0.9% | 0.5% | -0.9% | 5.9% | 5.6% | 6.3% | 1.8% | -0.8% | 9.3% |
| ROE | — | 0.0% | -6.0% | -1.4% | -3.5% | 6.4% | 5.8% | 7.3% | 2.3% | 5.7% | 9.6% |
Frequently asked questions
What is Icu Medical’s annual revenue?
$2.2B in fiscal 2025 and $2.2B over the twelve months to September 30, 2026.
How much profit does Icu Medical make?
Net income was $732000 in fiscal 2025 (net margin 0.0%).
Is Icu Medical’s revenue growing?
No: revenue fell 6.3% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.